vs

Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Black Stone Minerals, L.P. is the larger business by last-quarter revenue ($95.2M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). Black Stone Minerals, L.P. runs the higher net margin — 75.9% vs -38.1%, a 113.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -8.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -9.7%).

Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

BSM vs PRCT — Head-to-Head

Bigger by revenue
BSM
BSM
1.1× larger
BSM
$95.2M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+28.9% gap
PRCT
20.2%
-8.7%
BSM
Higher net margin
BSM
BSM
113.9% more per $
BSM
75.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-9.7%
BSM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BSM
BSM
PRCT
PRCT
Revenue
$95.2M
$83.1M
Net Profit
$72.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
78.6%
-4.1%
Net Margin
75.9%
-38.1%
Revenue YoY
-8.7%
20.2%
Net Profit YoY
55.8%
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSM
BSM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$95.2M
$76.4M
Q3 25
$105.2M
$83.3M
Q2 25
$106.7M
$79.2M
Q1 25
$115.3M
$69.2M
Q4 24
$104.3M
$68.2M
Q3 24
$103.2M
$58.4M
Q2 24
$115.2M
$53.4M
Net Profit
BSM
BSM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$72.2M
$-29.8M
Q3 25
$91.7M
$-21.4M
Q2 25
$120.0M
$-19.6M
Q1 25
$15.9M
$-24.7M
Q4 24
$46.3M
$-18.9M
Q3 24
$92.7M
$-21.0M
Q2 24
$68.3M
$-25.6M
Gross Margin
BSM
BSM
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
BSM
BSM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
78.6%
-40.6%
Q3 25
89.5%
-27.8%
Q2 25
-28.0%
Q1 25
14.9%
-39.7%
Q4 24
45.6%
-28.9%
Q3 24
90.2%
-38.4%
Q2 24
59.5%
-50.3%
Net Margin
BSM
BSM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
75.9%
-39.1%
Q3 25
87.2%
-25.7%
Q2 25
112.5%
-24.7%
Q1 25
13.8%
-35.8%
Q4 24
44.4%
-27.6%
Q3 24
89.9%
-35.9%
Q2 24
59.3%
-48.0%
EPS (diluted)
BSM
BSM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSM
BSM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$1.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
Total Assets
$1.3B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSM
BSM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$1.5M
$286.5M
Q3 25
$2.9M
$294.3M
Q2 25
$2.5M
$302.7M
Q1 25
$2.4M
$316.2M
Q4 24
$2.5M
$333.7M
Q3 24
$21.0M
$196.8M
Q2 24
$26.7M
$214.1M
Total Debt
BSM
BSM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
BSM
BSM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$380.3M
Q2 25
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
BSM
BSM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.3B
$508.1M
Q3 25
$1.3B
$511.5M
Q2 25
$1.3B
$513.1M
Q1 25
$1.2B
$519.4M
Q4 24
$1.2B
$534.0M
Q3 24
$1.2B
$374.1M
Q2 24
$1.2B
$374.4M
Debt / Equity
BSM
BSM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSM
BSM
PRCT
PRCT
Operating Cash FlowLast quarter
$65.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSM
BSM
PRCT
PRCT
Q1 26
Q4 25
$65.1M
$-10.3M
Q3 25
$99.8M
$-6.6M
Q2 25
$80.5M
$-15.0M
Q1 25
$64.8M
$-17.0M
Q4 24
$91.0M
$-32.4M
Q3 24
$93.2M
$-18.8M
Q2 24
$100.4M
$-15.7M
Free Cash Flow
BSM
BSM
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
BSM
BSM
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
BSM
BSM
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
BSM
BSM
PRCT
PRCT
Q1 26
Q4 25
0.90×
Q3 25
1.09×
Q2 25
0.67×
Q1 25
4.07×
Q4 24
1.96×
Q3 24
1.01×
Q2 24
1.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BSM
BSM

Oil Reserves$46.4M49%
Natural Gas Reserves$44.1M46%
Real Estate$4.7M5%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons